Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut
Drug developer Generate Biomedicines raises $400 million in US IPO
Generate Biomedicines aims to raise $425 million in US IPO